Gene · 6520
Papers4,329
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 4,329
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of Transport Proteins for the Renal Handling of L-Arginine and Related Derivatives. | Int J Mol Sci | 2025 | 40869219 | PubTator, text mining | PubMed |
| Mutational profile of oropharyngeal squamous cell carcinoma in relation to HPV, tobacco smoking and prognosis with validation in the DAHANCA 19 randomized trial. | Acta Oncol | 2025 | 40859705 | PubTator, text mining | PubMed |
| Advances in novel cell death mechanisms in breast cancer: intersecting perspectives on ferroptosis, cuproptosis, disulfidptosis, and pyroptosis. | Mol Cancer | 2025 | 40859310 | PubTator, text mining | PubMed |
| Ioning out glioblastoma: ferroptosis mechanisms and therapeutic frontiers. | Cell Death Discov | 2025 | 40858533 | PubTator, text mining | PubMed |
| Exploring the role of ferroptosis in esophageal cancer: mechanisms and therapeutic implications. | Cell Death Discov | 2025 | 40855044 | PubTator, text mining | PubMed |
| Emerging dual role of ferroptosis in lung cancer (Review). | Oncol Rep | 2025 | 40849820 | PubTator, text mining | PubMed |
| L‑type amino acid transporter 1 in enhancing boron neutron capture therapy: Mechanisms, challenges and future directions (Review). | Int J Mol Med | 2025 | 40849804 | PubTator, text mining | PubMed |
| Mechanism of xihuang pill inhibition of SLC7A11 deubiquitination through downregulation of the OTUB1 to promote ferroptosis in triple-negative breast cancer. | J Ethnopharmacol | 2025 | 40846041 | PubTator, text mining | PubMed |
| Sulfasalazine induces ferroptosis in osteosarcomas by regulating Nrf2/SLC7A11/GPX4 signaling axis. | Sci Rep | 2025 | 40825957 | PubTator, text mining | PubMed |
| Oroxin A suppresses colorectal tumor growth by regulating the TRIM24-mediated ferroptosis and TSPO pathway. | iScience | 2025 | 40822356 | PubTator, text mining | PubMed |
| Comparative proteomics of HepG2 cells reveals NGLY1 as an important regulator of ferroptosis resistance and iron uptake. | PLoS One | 2025 | 40811347 | PubTator, text mining | PubMed |
| D-cysteine impairs tumour growth by inhibiting cysteine desulfurase NFS1. | Nat Metab | 2025 | 40797101 | PubTator, text mining | PubMed |
| Chimeric SF-25 monoclonal antibody as a targeted therapy for SLC3A2 in adult T-cell leukemia/lymphoma. | Sci Rep | 2025 | 40790328 | PubTator, text mining | PubMed |
| Structural insights into the substrate transport mechanism of the amino acid transporter complex. | J Biol Chem | 2025 | 40780412 | PubTator, text mining | PubMed |
| Ferroptosis: a key driver and therapeutic target in the pathogenesis of acute respiratory distress syndrome. | Front Immunol | 2025 | 40766305 | PubTator, text mining | PubMed |
| The EMC acts as a chaperone for membrane proteins. | Nat Commun | 2025 | 40753078 | PubTator, text mining | PubMed |
| Proteomic analysis of tumor cell nuclear expulsion reveals significant cell adhesion and RNA binding programs in extracellular chromatin. | Sci Rep | 2025 | 40751052 | PubTator, text mining | PubMed |
| Pharmacodynamic analyses of LAT1 inhibitors in vitro and in vivo by targeted metabolomics reveal target-independent effects. | Biomed Pharmacother | 2025 | 40749339 | PubTator, text mining | PubMed |
| "Molecular pigeon" network of lncRNA and miRNA: decoding metabolic reprogramming in patients with lung cancer. | Front Oncol | 2025 | 40746614 | PubTator, text mining | PubMed |
| Comprehensive landscape of cell death mechanisms: from molecular cross-talk to therapeutic innovation in oncology. | Front Cell Dev Biol | 2025 | 40741332 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6520/papers?page=9